Since Ap exhibited high affinity to LRP1, here we used Ap to decorate on the surface of glycolipid-like nanoparticles (Ap-CSSA/DOX) for BBB targeting and brain tumor cascade-targeting, thus realizing GBM effective therapy. Here, LRP1 is linked to glioblastoma.